Drugs IDK Flashcards
cetuximab
anti-EGFR
rituximab
anti-CD20
eculizumab
anti complement C5
PNH
brentuximab vedotin
anti-CD30 conjugated to microtubule disrupting agent
“New Directions” for Hodgkins
ipilimumab
anti-CTLA4
tumors
nivolumab
anti-PD1
Hodgkins
imatinib
BCR-ABL inhibitor
CML
erlotinib
EGFR inhibitor
lung cancers
ibrutinib
bruton’s tyrosine kinase inhibitor
CLL
BTK needed for B cell survival
lenalidomide
imid (like thalidomide)
azacytidine
demethylating agent
decitabine
demethylating agent
aresenic trioxide ATO
alternative to ATRA for APL
romiplostim
Tpo mimetic
ITP
eltrombopag
Tpo mimetic
ITP
prochlorperazine
dopaminergic antagonist anti emetic (acute/delayed)
metoclopramide
dopaminergic antagonist anti emetic (acute/delayed)
epoetin alfa
- ESA
- short acting epo stimulation
- pts with chemo
darbepoeitin alfa
- ESA
- long acting epo stimulation
- pts with chemo
filgrastim
increases granulocytes (neutrophils)
pegfilgrastim
increases granulocytes (neutrophils) long acting
protamine sulfate
reversal of heparin anticoagulation
allopurinol
prevents accumulation of uric acid
tumor lysis syndrome
rasburicase
turns uric acid into allantoin
tumor lysis syndrome
diphenhydramine
counteract extrapyramidal effects of dopamine antagonists
fresh frozen plasma
all coagulation factors
cryoprecipitate
fibrinogen
vWF
VIII
XIII
anti-D immune globulin
against D antigen of Rh complex
prothrombin complex concentrates
activated factors
- vitamin K antagonists
- inhibitors
- bleeding disorders
albumin
capillary leak syndrome